Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01098994 · ClinicalTrials.gov registry record · NA
Haptoglobin Phenotype, Vitamin E and High-density Lipoprotein (HDL) Function in Type 1 Diabetes
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 87
- Enrollment target
NCT01098994 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 87 participants.
The verdict
NCT01098994, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 87 participants
- Enrollment target
Study Summary
The purpose of the study is to determine whether the function of the good cholesterol (HDL cholesterol) as well as its subfractions (via NMR spectroscopy) is altered among people with type 1 diabetes and a variation in the Haptoglobin gene and to evaluate whether vitamin E supplements may improve this function.
Interventions
- DIETARY_SUPPLEMENT Vitamin E
- OTHER Dummy pills
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2010-02 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01098994
The ClinicalTrials.gov registry entry for NCT01098994 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vitamin E is the first listed.
NCT01098994 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01098994 about?
NCT01098994 is a clinical study titled "Haptoglobin Phenotype, Vitamin E and High-density Lipoprotein (HDL) Function in Type 1 Diabetes". The purpose of the study is to determine whether the function of the good cholesterol (HDL cholesterol) as well as its subfractions (via NMR spectroscopy) is altered among people with type 1 diabetes and a variation in the Haptoglobin gene and to evaluate whether vitamin E supplements may improve th...
What is the current status of trial NCT01098994?
This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2010-02. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01098994?
The interventions under investigation include: Vitamin E (DIETARY_SUPPLEMENT), Dummy pills (OTHER).
Who is sponsoring clinical trial NCT01098994?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.